Edition:
India

Horizon Pharma PLC (HZNP.OQ)

HZNP.OQ on NASDAQ Stock Exchange Global Select Market

24.92USD
18 Apr 2019
Change (% chg)

$0.32 (+1.30%)
Prev Close
$24.60
Open
$24.57
Day's High
$25.06
Day's Low
$24.12
Volume
439,359
Avg. Vol
584,457
52-wk High
$29.44
52-wk Low
$12.58

Select another date:

Tue, Apr 16 2019

Recordati to seek Canadian approval for kidney disease drug

TORONTO Italy's Recordati said on Tuesday it plans to seek Canadian approval for its drug Cystagon, which treats a rare kidney disease, in a potential blow to Horizon Pharma,, which makes the only drug approved for treatment in Canada.

Recordati to seek Canadian approval for kidney disease drug

TORONTO, April 16 Italy's Recordati said on Tuesday it plans to seek Canadian approval for its drug Cystagon, which treats a rare kidney disease, in a potential blow to Horizon Pharma,, which makes the only drug approved for treatment in Canada.

Select another date: